Previous close | 40.64 |
Open | 40.65 |
Bid | 41.11 x 100 |
Ask | 41.20 x 100 |
Day's range | 40.00 - 41.23 |
52-week range | 20.68 - 47.74 |
Volume | |
Avg. volume | 686,025 |
Market cap | 3.116B |
Beta (5Y monthly) | 0.82 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.00 |
Earnings date | 08 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 53.30 |
IDEAYA Biosciences ( NASDAQ:IDYA ) First Quarter 2024 Results Key Financial Results Net loss: US$39.6m (loss widened by...
Comparative Analysis of Q1 Earnings Against Analyst Expectations and Future Projections
IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, provided a business update, and announced financial results for the first quarter ended March 31, 2024.